Well 5 January 2023 and we now wait on blood data from the first cohort of mnd patients which should show that mpl is safe, which we already knew from previous trialling but now appears to have overcome other adverse affects.
Hopefully the data also shows mpl has a positive affect for mnd patients
Once this data is analysis they could look at doing a phrase 2 covid trial, I would have liked them to also use the mnd data to progress to the long awaited human cancer phrase 2 trial, however this not mentioned in announcement.
We also now wait for quarterly and half yearly reports, maybe we will get an up date on OHD reactor.
So by February we may have some idea of the actual state of progress
Ann: MND Trial Completes Enrolment of First Patient Cohort, page-99
Add PAA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
20.0¢ |
Change
0.010(5.26%) |
Mkt cap ! $97.28M | |||
| Open | High | Low | Value | Volume |
| 19.0¢ | 20.5¢ | 19.0¢ | $326.8K | 1.645M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 138704 | 20.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 20.5¢ | 60000 | 1 |
View Market Depth
| Last trade - 16.10pm 25/09/2024 (20 minute delay) ? |
| PAA (ASX) Chart |